NSABP B-42: A clinical trial to determine the efficacy of five years of letrozole compared with placebo in patients completing five years of hormonal therapy consisting of an aromatase inhibitor (AI) or tamoxifen followed by an AI in prolonging disease-free survival in postmenopausal women with hormone receptor-positive breast cancer

Eleftherios P. Mamounas, Barry Lembersky, Jong Hyeon Jeong, Walter Cronin, Barbara Harkins, Charles Geyer, Donald Lawrence Wickerham, Soonmyung Paik, Joseph Costantino, Norman Wolmark

Research output: Contribution to journalArticlepeer-review

39 Scopus citations
Original languageEnglish (US)
Pages (from-to)416-421
Number of pages6
JournalClinical Breast Cancer
Issue number5
StatePublished - Dec 2006


  • Arterial thrombotic events
  • Duration of therapy
  • Early-stage disease
  • Osteoporotic fracture

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this